🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Writer Login
Latest
Priya Life Science Clinical trial register
Trackers Drugs Comparisons API
Trackers› Clinical trials› Ireland
Clinical trial register · Ireland

Studies with an Irish investigative site

Every study on the ClinicalTrials.gov registry that lists a site in Ireland and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Alert me on this filter Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 615 matching records held by the registry are in this view. Synced 23 Sep 2026, 03:15 UTC
615
Studies in scope
all four open statuses
321
Recruiting now
open to new participants
180
Lead sponsors
across recruiting studies
37
Irish site locations
across all listed studies
Phase mix of the 321 recruiting studies
Phase 3 96 Not applicable 79 Observational 76 Phase 2 30 Phase 1/2 20 Other 20
Narrow the register
Matches title, registry number, sponsor, intervention and condition.
Recruitment status
Phase
Lead sponsor
Merck Sharp & Dohme LLC 36 Royal College of Surgeons, Ireland 29 University College Dublin 21 AbbVie 20 University College Cork 19
Site location
Dublin 483 Cork 170 Galway 124 Limerick 56 Waterford 51
All 37 locations
Target enrolment
to
615 of 615 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Irish sites
Start
By invitation
Multicenter Prospective Cohort Study on Current Treatments of Legg-Calvé-Perthes Disease
NCT02040714 Legg Calve Perthes Disease
Texas Scottish Rite Hospital for Children
Observational
1,500
Dublin
2012-08
Recruiting
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
NCT01574053 Huntington's Disease
CHDI Foundation, Inc.
Observational
35,000
Dublin
2012-07
Recruiting
Product Surveillance Registry
NCT01524276 Cardiac Rhythm Disorders, Urological Disorders, Neurological Disorders, Cardiovascular Disorders
Medtronic
Observational
100,000
Galway
2012-01
Recruiting
Diagnostic and Therapeutic Applications in Microarrays in Organ Transplantation
NCT01299168 Validation Study of Molecular Diagnostic System, Development of Reporting System for Molecular Diagnosis, Incorporate Molecular Diagnosis Into Diagnostic Standards
University of Alberta
Observational
500
Dublin
2011-05
Active, closed
Tamoxifen Citrate, Letrozole, Anastrozole, or Exemestane With or Without Chemotherapy in Treating Patients With Invasive RxPONDER Breast Cancer
NCT01272037 Breast Ductal Carcinoma In Situ, Invasive Breast Carcinoma, Multicentric Breast Carcinoma, Multifocal Breast Carcinoma
National Cancer Institute (NCI)
Phase 3
5,018
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2011-02-28
Active, closed
Lenalidomide or Observation in Treating Patients With Asymptomatic High-Risk Smoldering Multiple Myeloma
NCT01169337 Light Chain Deposition Disease, Smoldering Multiple Myeloma
National Cancer Institute (NCI)
Phase 3
226
Dublin, Galway
2011-01-24
Active, closed
Male Breast Cancer: Understanding the Biology for Improved Patient Care
NCT01101425 Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Observational
200
Cork, Dublin, Waterford
2010-12
Active, closed
RT With or Without Cetuximab in Treating Patients Who Have Undergone Surgery for Locally Advanced Head and Neck Cancer
NCT00956007 Head and Neck Cancer
Radiation Therapy Oncology Group
Phase 3
702
2010-03-31
Active, closed
A Prospective Phase II Dose Escalation Study Using IMRT for High Risk N0 M0 Prostate Cancer. ICORG 08-17
NCT00951535 Prostate Cancer
Cancer Trials Ireland
Phase 2
251
Cork, Dublin
2009-07-20
Recruiting
Pharmacokinetics of Antiretroviral Agents in HIV-infected Pregnant Women.
NCT00825929 HIV Infections
Radboud University Medical Center
Observational
176
Dublin
2009-02
Active, closed
Phase III Trial of Anaplastic Glioma Without 1p/19q Loss of Heterozygosity (LOH)
NCT00626990 Brain and Central Nervous System Tumors
European Organisation for Research and Treatment of Cancer - EORTC
Phase 3
751
2007-12
Active, closed
Hormone Therapy With or Without Combination Chemotherapy in Treating Women Who Have Undergone Surgery for Node-Negative Breast Cancer (The TAILORx Trial)
NCT00310180 Breast Adenocarcinoma, Hormone Receptor Positive, Stage IA Breast Cancer AJCC v7, Stage IB Breast Cancer AJCC v7
National Cancer Institute (NCI)
Phase 3
10,273
Cork, Dublin, Mount Merrion, Galway, Limerick, Sligo, Waterford, Letterkenny
2006-04-07
Recruiting
High Risk Neuroblastoma Study 1.8 of SIOP-Europe (SIOPEN)
NCT01704716 Neuroblastoma
St. Anna Kinderkrebsforschung
Phase 3
3,300
Dublin
2002-02
Recruiting
Computerized Registry of Patients With Venous Thromboembolism (RIETE)
NCT02832245 Venous Thromboembolism
Manuel Monreal
Observational
120,000
Dublin
2001-03
By invitation
EuroSIDA - Clinical and Virological Outcome of European Patients Infected With HIV
NCT02699736 HIV, Hepatitis B, Hepatitis C, AIDS
Rigshospitalet, Denmark
Observational
23,000
Dublin
1994-01
Rows per page Showing 601–615 of 615
Previous 5 6 7
Cite this view

Priya Life Science (2026). Clinical trial register: studies with an Irish investigative site. Derived from ClinicalTrials.gov, U.S. National Library of Medicine. Retrieved 23 September 2026. https://priyalifescience.com/clinical-trials-ireland?page=7

Query this register directly
GET /api/trials?country=ie&status=recruiting&phase=Phase+3&format=json Try it now →
→

Browse trials by condition

Breast Cancer (22) Prostate Cancer (14) Cancer (11) Ulcerative Colitis (11) Multiple Myeloma (10) Crohn's Disease (9) Ovarian Cancer (8) Chronic Lymphocytic Leukemia (7) Non-small Cell Lung Cancer (7) Fallopian Tube Cancer (6) Hypertension (6) Vascular Diseases (6) Cardiovascular Diseases (6) Idiopathic Pulmonary Fibrosis (5) Amyotrophic Lateral Sclerosis (5)
→

Browse trials by site location

Dublin (483) Cork (170) Galway (124) Limerick (56) Waterford (51) Beaumont (13) Sligo (12) Drogheda (9) Elm Park (9) Crumlin (8) Letterkenny (7) Ballinasloe (7) Tallaght (7) Wilton (5) Manorhamilton (4)
Listing here is informational and not medical advice; eligibility is determined by each study team. Patients should discuss participation with their clinician. For trials across the wider EU, see the EU Clinical Trials Tracker.